Lataa...
High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis
Multiple sclerosis (MS) is an autoimmune, demyelinating disease and as such, the gold standard of treatment is to selectively suppress the pathogenic autoimmune response without compromising the entire arm of the adaptive immune response. One target of this strategy lying upstream of the pathologic...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672339/ https://ncbi.nlm.nih.gov/pubmed/23514872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2013.02.005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|